Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
LEO Innovation Lab
AddedFeb 16, 2024
UpdatedJun 28, 2026
LEO Innovation Lab

LEO Innovation Lab

LEO Innovation Lab, a LEO Pharma unit, focuses on patient needs in pharmaceutical manufacturing.

HQ
Copenhagen, Capital Region of Denmark, DK
Founded
2015
Overview
Compare
Employees

LEO Innovation Lab, a unit of LEO Pharma, focuses on addressing patient needs in pharmaceutical manufacturing. The company aims to innovate in healthcare by developing solutions that improve patient outcomes. Their market focus includes creating patient-centric products and services that enhance the quality of life for individuals with chronic conditions.

LEO Innovation Lab has achieved significant milestones in healthcare innovation, contributing to advancements in patient care. Their impact is evident in the development of new treatments and technologies that cater to unmet medical needs. The organization collaborates with various stakeholders to drive progress in the pharmaceutical industry.

LEO Innovation Lab - Similar Companies

Leo Health logo

Leo Health

leohealth.com

Eolo Pharma logo

Eolo Pharma

eolo-pharma.com

PleoPharma logo

PleoPharma

pleopharma.com

Leuko logo

Leuko

leuko.io

Jlabs logo

Jlabs

LeO logo

LeO

meetleo.co

Leucine logo

Leucine

leucinetech.com

Leverage Health logo

Leverage Health

leveragehealth.com

BiotechInnova logo

BiotechInnova

biotechinnova.com

Incube Labs logo

Incube Labs

incubelabs.com

Innovation1 Biotech logo

Innovation1 Biotech

Turek Labs logo

Turek Labs

Elixir Lab logo

Elixir Lab

MedLever logo

MedLever

medlever.com

HighlightLL Pharma logo

HighlightLL Pharma

LEO Innovation Lab - Quick Facts

Who are LEO Innovation Lab's competitors?

Companies similar to LEO Innovation Lab include Leo Health, Eolo Pharma, PleoPharma and Leuko.

When was LEO Innovation Lab founded?

LEO Innovation Lab was founded in 2015.

Where is LEO Innovation Lab's headquarters located?

LEO Innovation Lab's headquarters is located in Copenhagen, Capital Region of Denmark, DK.

How many employees does LEO Innovation Lab have?

LEO Innovation Lab has 175 employees as of Feb 4, 2024.

LEO Innovation Lab - Classification

Ownership
  • Private
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software